NCT06398288View on ClinicalTrials.gov

Adjunctive Use of Dermal Matrix to Compensate Dimensional Changes in the Reconstructive Therapy of Peri-implantitis

NARecruitingINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

March 1, 2024

Primary Completion Date

March 1, 2025

Study Completion Date

March 1, 2026

Conditions
Peri-Implantitis
Interventions
OTHER

Dermal matrix (Oracell, LifeNet, USA)

Mechanical detoxification using curettes + NiTi brushes + EA (GalvoSurge) for 2 minutes + a mixture of anorganic bovine bone (Straumann Xenograft, Straumann) and cortical mineralized/demineralized allograft (Oragraft, Lifenet Health) + dermal matrix on the buccal aspect (Oracell, Lifenet Health)

OTHER

No dermal matrix

Mechanical detoxification using curettes + NiTi brushes + EA (GalvoSurge) for 2 minutes + a mixture of anorganic bovine bone (Straumann Xenograft, Straumann) and cortical mineralized/demineralized allograft (Oragraft, Lifenet Health)

Trial Locations (1)

06001

RECRUITING

Centro de Implantologia Cirugia Oral y Maxiofacial, Badajoz

All Listed Sponsors
lead

Center of Implantology, Oral and Maxillofacial Surgery, Badajoz, Spain

OTHER